Kura Oncology, Inc. (KURA)
9.28
+0.07
(+0.76%)
USD |
NASDAQ |
Jan 14, 14:04
Kura Oncology EPS Diluted (Quarterly): -0.8456 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -1.567 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Electromed, Inc. | 0.246 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.12M |
| Revenue (Quarterly) | 20.75M |
| Total Expenses (Quarterly) | 94.87M |
| Enterprise Value | 271.23M |
| Gross Profit Margin (Quarterly) | 99.21% |
| Profit Margin (Quarterly) | -357.2% |
| Earnings Yield | -26.70% |
| Normalized Earnings Yield | -26.70 |